-
Nuvation Bio Receives Approval from Japan's Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
19 Sep 2025 14:30 GMT
… and/or recurrent non-small cell lung cancer (NSCLC). As part of an … globally are diagnosed with non-small cell lung cancer (NSCLC), the most common form … advanced or metastatic ROS1+ non-small cell lung cancer (NSCLC). IMPORTANT SAFETY INFORMATION FOR …
-
Peritoneal Metastasis in Non-Small Cell Lung Cancer: A Systematic Review of Clinical Features, Molecular Profiles, Diagnostic Approaches, and Outcomes
19 Sep 2025 09:19 GMT
Introduction
Non-small cell lung cancer (NSCLC) accounts for … ; NGS, Next-Generation Sequencing; NSCLC, Non-Small Cell Lung Cancer; OS, Overall Survival; PC … ) of EGFR mutation-positive non-small cell lung cancer (NSCLC) patients: real-world treatment …
-
<![CDATA[Evaluating the Top EGFR+ NSCLC Treatment Combinations]]>
20 Sep 2025 15:20 GMT
… non–small cell lung cancer (NSCLC) is continuously evolving and advancing …
-
Combined Detection of Tumor Stem Cell Markers CD133 and OCT4 in Early Non-Small Cell Lung Cancer Screening and Prognostic Evaluation
19 Sep 2025 04:26 GMT
Introduction
Non-small cell lung cancer (NSCLC) is the most common … independent predictors of relapse in non-small cell lung cancer: secondary analysis of a … prediction in stage I-III non-small cell lung cancer assessed by multiplex immunofluorescence. …
-
<![CDATA[FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC]]>
20 Sep 2025 07:20 GMT
… –small cell lung cancer (NSCLC) without abnormal EGFR or … efficacy in patients with NSCLC who were treatment naive … alone for use in NSCLC compared with intravenous use … with metastatic squamous or nonsquamous non-small cell lung cancer (NSCLC) (MK-3475-A86). …
-
<![CDATA[Intracranial Efficacy of Datopotamab Deruxtecan (DatoDXd) in Patients With Advanced/Metastatic NSCLC in TROPION-Lung01 ]]>
20 Sep 2025 07:32 GMT
-
Dermatotoxicity of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Advances in Mechanistic Insights and Predictive Biomarker Identification
17 Sep 2025 09:09 GMT
… for advanced and metastatic non-small cell lung cancer (NSCLC).2 These agents, … checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC). J UOEH. 2018;40 … resistance to immunotherapy in non-small cell lung cancer (NSCLC). Transl Lung Cancer Res …
-
<![CDATA[Taletrectinib Wins Japanese Approval for ROS1+ Advanced NSCLC]]>
20 Sep 2025 01:10 GMT
… or metastatic, ROS1-positive NSCLC.3
“Building on the … with advanced ROS1-positive NSCLC around the globe," … or metastatic, ROS1-positive NSCLC.1,2 Patients naive … patients with advanced ROS1-positive non-small cell lung cancer. News release. Nuvation Bio …
-
Zidesamtinib Active, Safe in Pretreated ROS1+ Advanced NSCLC
19 Sep 2025 19:24 GMT
… with advanced ROS1-positive NSCLC, zidesamtinib demonstrated a clinical … with advanced ROS1-positive NSCLC and other solid tumors. … with ROS1 TKI–pretreated NSCLC with measurable disease by … advanced/metastatic ROS1+ NSCLC. Presented at: 2025 International …
-
3 Things You Should Know About New Treatments for MET-Altered NSCLC
19 Sep 2025 14:51 GMT
… need: targeting MET in non-small cell lung cancer. Front Oncol. 2022;12 … advanced nonsquamous EGFR-wildtype non-small cell lung cancer in the phase II … with previously treated non-squamous non-small cell lung cancer (NSCLC). ClinicalTrials.gov. Updated July …
About
© 1995-2025